Heart disease and stroke deaths take a downturn, AHA report reveals
A new report from the American Heart Association (AHA) has found that US cardiovascular disease (CVD)-related deaths declined between 2022…
22 Jan 2026
Johnson & Johnson reports 9.1% increase in sales for Q4 2025
Johnson & Johnson (J&J) has reported a 9.1% increase in sales for Q4 2025, reaching $24.56bn, with net earnings rising by 49.1% to $5.11bn. For the entire year, sales grew…
22 Jan 2026
Opna Bio’s OPN-2853 secures FDA’s orphan drug status for myelofibrosis
Opna Bio has received the US Food and Drug Administration’s (FDA) orphan drug designation for OPN-2853 (zavabresib), a bromodomain and extra-terminal motif (BET) small molecule inhibitor, to treat myelofibrosis. The…
21 Jan 2026
Davos26: Trump says tariff threats helped fix US drug pricing ‘unfairness’
The threat of tariffs was necessary to get major drugmakers and foreign leaders on board with drug pricing reforms in the US, President Donald Trump has said. During an address…
21 Jan 2026
Pfizer and Novavax ink $530m vaccine delivery licensing deal
Pfizer has signed a deal worth up to $530m with US-based vaccine technology company Novavax. This agreement will see Pfizer hand over $30m upfront for the non-exclusive rights to Novavax’s…
21 Jan 2026
BMS and Microsoft partner for AI-based lung cancer detection
Bristol Myers Squibb (BMS) has entered an agreement with Microsoft to advance AI-driven early lung cancer detection. The collaboration will deploy radiology AI algorithms cleared by the US Food and…
21 Jan 2026
Novo Nordisk and Aspect Biosystems advance partnership for diabetes therapies
Novo Nordisk and Aspect Biosystems have commenced a new phase in their ongoing partnership focused on curative cellular medicines to treat diabetes. The collaboration, which began in 2023, aims to…